Associates of Cape Cod

Executive Summary

Associates of Cape Cod (ACC) is a privately held global leader in endotoxin and glucan detection products and services, with over 45 years of industry experience. Headquartered in East Falmouth, Massachusetts, ACC provides critical quality control solutions for the pharmaceutical, biotechnology, and medical device industries. Its core offerings include Limulus Amebocyte Lysate (LAL) and recombinant Factor C (rFC) assays, which are essential for detecting endotoxins in injectable drugs and medical devices. Given the increasing regulatory scrutiny and demand for high-quality biologics, ACC is well-positioned to benefit from the growth in parenteral drug development. Despite being a private company with limited public disclosure, ACC's sustained market presence and specialized expertise suggest a stable business with moderate growth potential. The company likely generates recurring revenue from consumables and testing services, and its customer relationships within the regulated pharmaceutical sector provide a defensible moat.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Recombinant Endotoxin Detection Assay70% success
• Q4 2026Expansion into Asian Biopharma Market50% success